Cargando…

Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients?

Detalles Bibliográficos
Autor principal:	Park, Hee Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780446/ https://www.ncbi.nlm.nih.gov/pubmed/26934882 http://dx.doi.org/10.5009/gnl16014

Ejemplares similares

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results
por: Bae, Sun Hyun, et al.
Publicado: (2017)

A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2016)

Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
por: Goto, Yoko, et al.
Publicado: (2018)

Recurrence patterns of pancreatic cancer treated with adjuvant intensity modulated radiotherapy
por: Yıldırım, Halil Cumhur, et al.
Publicado: (2022)

Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
por: Oh, Eun Sang, et al.
Publicado: (2018)

Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer
por: Nakamura, Akira, et al.
Publicado: (2018)

Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Intensity-modulated radiotherapy for prostate cancer
por: Fischer-Valuck, Ben W., et al.
Publicado: (2018)

Intensity modulated radiotherapy for elderly bladder cancer patients
por: Hsieh, Chen-Hsi, et al.
Publicado: (2011)

Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?
por: Yu, De-Yang, et al.
Publicado: (2020)

Is Health Screening Beneficial for Early Detection and Prognostic Improvement in Pancreatic Cancer?
por: Kim, Eun Ran, et al.
Publicado: (2011)

The Current Evidence of Intensity-Modulated Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Jang, Won Il, et al.
Publicado: (2023)

Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy
por: Sinn, M., et al.
Publicado: (2014)

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
por: Iwai, Takahiro, et al.
Publicado: (2020)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy
por: Yang, Jen-Fu, et al.
Publicado: (2016)

Hypofractionated intensity-modulated radiotherapy in patients with localized prostate cancer: a preliminary study
por: Kang, Hye Jin, et al.
Publicado: (2016)

Intensity-modulated radiotherapy—what is it?
por: Taylor, A, et al.
Publicado: (2004)

Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis
por: Wang, Zheng, et al.
Publicado: (2015)

Dosimetric Comparison of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy and Hybrid Three-Dimensional Conformal Radiotherapy/Intensity-Modulated Radiotherapy Techniques for Right Breast Cancer
por: Liu, Yi-Chi, et al.
Publicado: (2020)

Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020
por: Hanna, C.R., et al.
Publicado: (2021)

Can ageing be beneficial?
por: Frenk, Stephen, et al.
Publicado: (2017)

Dosimetric comparison of intensity‐modulated radiotherapy and volumetric‐modulated arc radiotherapy in patients with prostate cancer: a meta‐analysis
por: Ren, Wenting, et al.
Publicado: (2016)

Ultrasound Is Beneficial to Determine Lymphadenopathy in Oral Cancer Patients after Radiotherapy
por: Cheng, Ping-Chia, et al.
Publicado: (2023)

Effects of intensity-modulated radiotherapy and chemoradiotherapy on attention in patients with nasopharyngeal cancer
por: Wei, Qing, et al.
Publicado: (2017)

Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy
por: Ma, Ningyi, et al.
Publicado: (2017)

Synergy of cancer immunotherapy and radiotherapy
por: Mansfield, Aaron S., et al.
Publicado: (2015)

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020)

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
por: Fornacon-Wood, Isabella, et al.
Publicado: (2022)

Ethics of Live Surgery Demonstration or Broadcast: Is It Beneficial to the Patients?
por: Min, Seung-Kee
Publicado: (2020)

Harmful and Beneficial Role of ROS
por: Di Meo, Sergio, et al.
Publicado: (2016)

Oviposition Strategies in Beneficial Insects
por: Riddick, Eric W, et al.
Publicado: (2018)

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
por: KIM, MIN-JEONG, et al.
Publicado: (2013)

Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer
por: Kim, Dong Wook, et al.
Publicado: (2013)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Forward‐planning intensity‐modulated radiotherapy technique for prostate cancer
por: Metwaly, Mohamed, et al.
Publicado: (2007)

Intensity-modulated radiotherapy for synchronous cancer of the anal canal and cervix
por: Kawamoto, Terufumi, et al.
Publicado: (2018)

Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)
por: Peponi, Evangelia, et al.
Publicado: (2011)

Clinical analysis of conformal and intensity-modulated radiotherapy in patients with recurrent ovarian cancer
por: Yang, Hua, et al.
Publicado: (2020)

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer
por: He, Fang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j203sg2dq9m75mrt2q21buo9e4